Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer. Clinics, [S. l.], v. 75, p. e993, 2020. DOI: 10.6061/clinics/2020/e993. Disponível em: https://www.revistas.usp.br/clinics/article/view/167124.. Acesso em: 4 may. 2024.